Preparation for cardio-cerebral blood vessel diseases and its preparing method

A preparation for the treatment of cardiovascular and cerebrovascular diseases, characterized in that it comprises two components both having a quasi-molecular ion mass peak m/z of 537[M-H]−, a second fragment ion m/z of 493[M-H-CO2]− and 295[M-CO2-R-H2O]−, and a third fragment ion m/z of 159 and 109, with the maximum absorption wave length of 327 nm, wherein the mass spectrum analysis is carried out as follows:

• (1) HPLC-MS is carried out through the negative ion detection under following conditions of dry gas flow rate:
• 10 L/min;
• nebulizer pressure:
• 60 psi;
• dry gas temperature:
• 350° C.;
• capillary voltage:
• 3500 v;
• and m/z scan range:
• 100-1200;
• and
• (2) HPLC-MSn is carried out through the negative ion detection under following conditions of dry gas flow rate:
• 10 L/min;
• nebulizer pressure:
• 60 psi;
• dry gas temperature:
• 350° C.;
• capillary voltage:
• 3500 v;
• m/z scan range:
• 100-800;
• and fragment amplitude:
• 1.5-3.0 v.